Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
Clinical trial NCT03091491 · TERMINATED
Trial details
- NCT number
- NCT03091491
- Sponsor
- National Cancer Centre, Singapore
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-07
- Primary completion
- 2019-11-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.